Flavonoids are natural polyphenolic compounds which are included in a panoply of drugs
and used to treat and/or manage human ailments such as metabolic, cardiovascular …

We reviewed the most relevant aspects of TB infection in SLE patients, including the burden
of TB, its role in inducing flare and its perpetuation, risk evaluation and prevention, and …

Objective. To evaluate the use and efficacy of belimumab in academic practices. Belimumab
is a human monoclonal antibody that inhibits soluble B lymphocyte stimulator and has been …

OBSErve Germany was the first observational study of belimumab as add-on treatment for
systemic lupus erythematosus (SLE) in routine clinical care in Germany, retrospectively …

Background Belimumab is a monoclonal antibody that reduces B lymphocyte survival by
blocking the binding of soluble human B lymphocyte stimulator (BLyS) to its B cell receptors …

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease presenting highly
heterogeneous clinical manifestations and multi-systemic involvement. Patients are …

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) comprises several
clinical entities with diverse clinical presentations, outcomes, and nonunifying pathogenesis …

Systemic lupus erythematosus (SLE) is a complex autoimmune rheumatic disease with
multiple presentations, whose management presents many challenges. Many disease …

B cells in general and BAFF (B cell activating factor of the tumor necrosis factor [TNF] family)
in particular have been primary targets of recent clinical trials in systemic lupus …

The objective of the study was to evaluate prospectively real-life experience on the effect of
belimumab on patients with active systemic lupus erythematosus (SLE). Forty-eight patients …